Literature DB >> 31057062

Where Will We Draw the Line? Public Opinions of Human Gene Editing.

Kirsten A Riggan1, Richard R Sharp1, Megan Allyse1.   

Abstract

The application of gene editing technologies to prevent or mitigate genetic disease in humans is considered one of its most promising applications. However, as the technology advances, it is imperative to understand the views of the broader public on how it should be used. We conducted focus groups to understand public views on the ethical permissibility and governance of gene editing technologies in humans. A total of 50 urban and semirural residents in the upper Midwest took part in six focus groups. Participants expressed multiple concerns about nonmedical uses of gene editing and its potential for unknown harms to human health, and were divided as to whether the individual patient or "medical experts" should be charged with overseeing the scope of its application. As potential stakeholders, the perspectives from the general public are critical to assess as genome editing technologies advance toward the clinic.

Entities:  

Keywords:  North America; ethics; genetics; health; moral perspectives; qualitative research

Mesh:

Year:  2019        PMID: 31057062     DOI: 10.1177/1049732319846867

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  5 in total

1.  Attitudes of Members of Genetics Professional Societies Toward Human Gene Editing.

Authors:  Alyssa J Armsby; Yvonne Bombard; Nanibaa' A Garrison; Bonnie L Halpern-Felsher; Kelly E Ormond
Journal:  CRISPR J       Date:  2019-10

2.  The View from the Benches: Scientists' Perspectives on the Uses and Governance of Human Gene-Editing Research.

Authors:  Margaret Waltz; Eric T Juengst; Teresa Edwards; Gail E Henderson; Kristine J Kuczynski; John M Conley; Paige Della-Penna; R Jean Cadigan
Journal:  CRISPR J       Date:  2021-08

3.  Toward Anticipatory Governance of Human Genome Editing: A Critical Review of Scholarly Governance Discourse.

Authors:  John P Nelson; Cynthia L Selin; Christopher T Scott
Journal:  J Responsible Innov       Date:  2021-07-29

4.  The 'serious' factor in germline modification.

Authors:  Erika Kleiderman; Vardit Ravitsky; Bartha Maria Knoppers
Journal:  J Med Ethics       Date:  2019-07-20       Impact factor: 2.903

5.  A CRISPR response to pandemics?: Exploring the ethics of genetically engineering the human immune system.

Authors:  Federico Germani; Sebastian Wäscher; Nikola Biller-Andorno
Journal:  EMBO Rep       Date:  2021-02-21       Impact factor: 8.807

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.